Discover a recent study that found that microultrasonography-guided biopsy could provide an alternative to MRI.

Microultrasonography-guided biopsy is as effective as MRI fusion-guided biopsy for detecting Gleason Grade Group 2 or higher prostate cancer, investigators reported during a game-changing trials ...

Micro-ultrasound–guided biopsies were ... who are at increased risk of prostate cancer may safely undergo a micro-ultrasound–guided biopsy rather than an MRI-guided biopsy,” said Adam ...

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer ...

To perform prostate cancer biopsies, doctors use a technology called MRI fusion-guided biopsy. This technique combines MRI with a transrectal ultrasound to more precisely sample prostate tissue. The ...

This is a TRUS guided biopsy. It can help to diagnose prostate cancer. You usually have an MRI scan before your TRUS guided biopsy. The MRI scan helps your doctor decide whether you need a biopsy and ...

High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively ...

Cancer in this third group was identified as effectively as MRI-guided biopsy, with similar rates of detection across all arms of the trial. Prostate cancer is the most diagnosed form of cancer in ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly improved detection of clinically important disease. This approach caught ...

Cancer in this third group was identified as effectively as MRI-guided biopsy, with similar rates of detection across all arms of the trial. Prostate cancer is the most diagnosed form of cancer in ...